Vitamin D3 for Life

Live Enlightened

Article

Why VDR Presence Is Not the Same as Vitamin D Response

Previous related pageWhy CYP27B1 and CYP24A1 Behave Differently Across TissuesNext related pageVitamin D and Transcription Factors
Study at a glance

Does finding a vitamin D receptor mean a cell is responding to vitamin D?

No. The vitamin D receptor is one part of the signalling system. Its presence does not show that active vitamin D has reached it or that the cell is changing its behaviour.

What else determines a cell’s vitamin D response?

The response depends on receptor amount, the signal reaching it, access to the cell’s genetic material and other proteins that help control gene activity. Feedback within and between tissues adds further influences.

Why can two studies give different pictures of vitamin D activity?

They may measure different steps. Detecting a receptor, showing that it binds a molecule, measuring a gene response and observing a change in tissue function answer different questions. Evidence for one step does not prove all the others.

Read the full article below ↓

Finding the vitamin D receptor in a cell is not the same as proving that the cell is currently responding to vitamin D. VDR presence is one layer in a chain of events. Biological response depends on how much receptor is present, whether an appropriate ligand reaches it, whether relevant genomic regions are accessible and whether downstream transcriptional and physiological machinery can execute the signal.

Layer 1: receptor presence

A VDR Tissue Distribution and Measurement Reliability study can establish that VDR protein or transcript is detectable in a tissue or cell population. That is important because a cell cannot use a receptor it truly does not possess. But detection is a capacity statement, not an activity statement.

Measurement also has limits. Antibody specificity, detection thresholds and cell heterogeneity can make VDR appear broader or narrower depending on the assay. Genetic negative controls are especially useful when receptor abundance is low.

Layer 2: receptor abundance and stability

The amount of VDR available to a cell can change. Enhancer regulation alters VDR gene expression, and receptor protein can be stabilised or degraded. In activated human CD4+ T cells, vitamin D-associated protection from proteasomal degradation provides one example of regulated receptor persistence.

Even here, more receptor does not map automatically to a proportionally greater physiological response. In mouse rescue models, comparatively restricted or lower receptor expression can remain sufficient for substantial biological correction.

Layer 3: ligand engagement

VDR must be in a molecular state capable of signalling. Calcitriol binding changes the ligand-binding domain and facilitates regulatory interactions. Alternative ligands can also occupy the receptor under particular conditions, but ligand occupancy alone still does not establish the final response.

Layer 4: genomic access

The receptor must operate within chromatin. Genome-wide studies show that VDR occupancy is cell specific and dynamic. A potential response element can be inaccessible in one cell and available in another. Collaborating transcription factors and enhancer architecture further shape which genes can respond.

This is why two cell types with detectable VDR can show different transcriptional programmes after the same ligand exposure.

Layer 5: transcriptional execution

VDR usually acts with RXR and regulatory protein complexes. DNA binding, coregulator recruitment and chromatin remodelling determine whether a locus is activated, repressed or largely unchanged. Direct receptor effects can also initiate secondary transcriptional cascades, adding another source of divergence between cells. The broader downstream framework is developed in Vitamin D and Gene Expression.

Layer 6: tissue physiology

A transcriptional response becomes biologically meaningful only when it alters cell or tissue function. Tissue-specific knockout and rescue models show this final layer clearly: receptor expression in particular intestinal compartments can be causally important for whole-body calcium and bone physiology.

A receptor therefore can be present without being the rate-limiting determinant of the final phenotype. Conversely, modest receptor expression can be sufficient when the rest of the signalling pathway is favourable.

Why ‘receptor sensitivity’ is an incomplete shortcut

The phrase can obscure several separate variables: receptor amount, ligand exposure, chromatin accessibility, cofactor availability, gene-network state and tissue-level feedback. Any one of these can affect apparent responsiveness. Treating all variation as a difference in receptor ‘sensitivity’ risks assigning the mechanism to the wrong layer.

For receptor abundance itself, see VDR Abundance, Regulation and Receptor Turnover. For the genomic layer, see VDR Cistrome, Chromatin and 3D Genome Organisation.

A better way to read VDR evidence

Ask which layer the experiment actually measures. Immunostaining measures localisation. A Western blot measures detectable protein in an extract. Ligand-binding studies measure receptor: ligand interaction. ChIP-seq measures genomic occupancy. RNA-seq measures transcriptional consequences. Knockout or rescue models test causal physiological function.

Those methods are complementary because they answer different questions. Problems arise when evidence from one layer is used as if it proves every later layer.

The central interpretation

VDR presence means that receptor-mediated signalling is possible; it does not mean that signalling is active, strong or physiologically decisive at that moment. Vitamin D response emerges from a sequence of conditional layers. Keeping those layers separate makes receptor biology more accurate and explains why expression maps alone cannot predict biological effect.

Return to Vitamin D Receptors.

Primary evidence used in this synthesis

  • Structural basis of VDR-DNA interactions on direct repeat response elements · Paul L. Shaffer, Daniel T. Gewirth. PMID 11980721; PMCID PMC125986; DOI 10.1093/emboj/21.9.2242.
  • The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights · J. Wesley Pike, Mark B. Meyer, Seong-Min Lee, Melda Onal, Nancy A. Benkusky. PMID 28240603; PMCID PMC5373853; DOI 10.1172/JCI88887.
  • Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay. PMID 18694980; PMCID PMC2583388; DOI 10.1210/er.2008-0004.
  • Identification of the vitamin D receptor in various cells of the mouse kidney · Yongji Wang, Rachael L Borchert, Hector F DeLuca. PMID 22278022; PMCID PMC3343313; DOI 10.1038/ki.2011.463.
  • Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A. Bishop, Joseph J. Goellner, Charles A. O’Brien, J. Wesley Pike. PMID 24693968; PMCID PMC4020932; DOI 10.1210/en.2014-1107.
  • Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription · Lee A. Zella, Mark B. Meyer, Robert D. Nerenz, Seong-Min Lee, Melissa L. Martowicz, J. Wesley Pike. PMID 19897601; PMCID PMC2802900; DOI 10.1210/me.2009-0140.
  • The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B. Meyer, Nancy A. Benkusky, Charles A. O’Brien, J. Wesley Pike. PMID 28602960; PMCID PMC5723236; DOI 10.1016/j.jsbmb.2017.06.002.
  • Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor · Carsten Carlberg, Moray J. Campbell. PMID 23178257; PMCID PMC4668715; DOI 10.1016/j.steroids.2012.10.019.
  • A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution · Sreeram V. Ramagopalan, Andreas Heger, Antonio J. Berlanga, Narelle J. Maugeri, Matthew R. Lincoln, Amy Burrell, Lahiru Handunnetthi, Adam E. Handel, Giulio Disanto, Sarah-Michelle Orton, Corey T. Watson, Julia M. Morahan, Gavin Giovannoni, Chris P. Ponting, George C. Ebers, Julian C. Knight. PMID 20736230; PMCID PMC2945184; DOI 10.1101/gr.107920.110.
  • Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF · Sabine Seuter, Antonio Neme, Carsten Carlberg. PMID 26715761; PMCID PMC4872072; DOI 10.1093/nar/gkv1519.
  • A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes · Timothy Warwick, Marcel H Schulz, Stefan Günther, Ralf Gilsbach, Antonio Neme, Carsten Carlberg, Ralf P Brandes, Sabine Seuter. PMID 33753848; PMCID PMC7985518; DOI 10.1038/s41598-021-86032-5.
  • Nuclear receptor activation shapes spatial genome organization essential for gene expression control: lessons learned from the vitamin D receptor · Timothy Warwick, Marcel H. Schulz, Ralf Gilsbach, Ralf P. Brandes, Sabine Seuter. PMID 35325193; PMCID PMC9023275; DOI 10.1093/nar/gkac178.
  • Vitamin D Up-Regulates the Vitamin D Receptor by Protecting It from Proteasomal Degradation in Human CD4+ T Cells · Kongsbak M, von Essen MR, Boding L, et al. PMID 24792400; PMCID PMC4008591; DOI 10.1371/journal.pone.0096695.

Related reading

Original sources

Source

Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice

Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay.

Publication details

Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay. PMID 18694980; PMCID PMC2583388; DOI 10.1210/er.2008-0004.

Read more →
Source

Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype

Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A.

Publication details

Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A. Bishop, Joseph J. Goellner, Charles A. O’Brien, J. Wesley Pike. PMID 24693968; PMCID PMC4020932; DOI 10.1210/en.2014-1107.

Read more →
Source

The impact of VDR expression and regulation in vivo

The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B.

Publication details

The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B. Meyer, Nancy A. Benkusky, Charles A. O’Brien, J. Wesley Pike. PMID 28602960; PMCID PMC5723236; DOI 10.1016/j.jsbmb.2017.06.002.

Read more →
Source

A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution

A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution · Sreeram V.

Publication details

A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution · Sreeram V. Ramagopalan, Andreas Heger, Antonio J. Berlanga, Narelle J. Maugeri, Matthew R. Lincoln, Amy Burrell, Lahiru Handunnetthi, Adam E. Handel, Giulio Disanto, Sarah-Michelle Orton, Corey T. Watson, Julia M. Morahan, Gavin Giovannoni, Chris P. Ponting, George C. Ebers, Julian C. Knight. PMID 20736230; PMCID PMC2945184; DOI 10.1101/gr.107920.110.

Read more →
Source

Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF

Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF · Sabine Seuter, Antonio Neme, Carsten Carlberg.

Publication details

Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF · Sabine Seuter, Antonio Neme, Carsten Carlberg. PMID 26715761; PMCID PMC4872072; DOI 10.1093/nar/gkv1519.

Read more →
Source

A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes

The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).

Publication details

A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes · Timothy Warwick, Marcel H Schulz, Stefan Günther, Ralf Gilsbach, Antonio Neme, Carsten Carlberg, Ralf P Brandes, Sabine Seuter. PMID 33753848; PMCID PMC7985518; DOI 10.1038/s41598-021-86032-5.

Read more →
Source

Nuclear receptor activation shapes spatial genome organization essential for gene expression control: lessons learned from the vitamin D receptor

Nuclear receptor activation shapes spatial genome organization essential for gene expression control: lessons learned from the vitamin D receptor · Timothy Warwick, Marcel H.

Publication details

Nuclear receptor activation shapes spatial genome organization essential for gene expression control: lessons learned from the vitamin D receptor · Timothy Warwick, Marcel H. Schulz, Ralf Gilsbach, Ralf P. Brandes, Sabine Seuter. PMID 35325193; PMCID PMC9023275; DOI 10.1093/nar/gkac178.

Read more →